aluates Reports

$ 0.0

Automative

Global Age Related Macular Degeneration Treatment Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-14U5993

Global Age Related Macular Degeneration Treatment Market Insights Forecast to 2028

BUY CHAPTERS

Global Age Related Macular Degeneration Treatment Market Insights, Forecast to 2030

Code: QYRE-Auto-14U5993

Report

December 2024

Pages:93

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Regeneron Pharmaceuticals

Bayer HealthCare

Novartis

Roche

Kanghong Pharma

Age Related Macular Degeneration Treatment Market Size

The global Age Related Macular Degeneration Treatment market is projected to grow from US$ 8128 million in 2024 to US$ 9592.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.8% during the forecast period.

Age Related Macular Degeneration Treatment Market

Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.

Market Analysis and Insights: Global Age Related Macular Degeneration Treatment Market

The age-related macular degeneration (AMD) treatment market is driven by the increasing prevalence of AMD, particularly in the aging population. As the global elderly population grows, the demand for effective treatment options to manage and slow down AMD progression rises. Additionally, advancements in medical research and technology have led to the development of novel therapies, such as anti-VEGF drugs, which have significantly improved visual outcomes for AMD patients. However, challenges exist, including the high cost of treatment, especially for long-term therapies, and the need for early detection and diagnosis to ensure timely intervention. Overcoming these challenges through affordable treatment options, patient education, and continued research to identify new therapeutic targets will be crucial for the sustained growth of the age-related macular degeneration treatment market.

Report Covers:

This report presents an overview of global market for Age Related Macular Degeneration Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Age Related Macular Degeneration Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Age Related Macular Degeneration Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Age Related Macular Degeneration Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Age Related Macular Degeneration Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Age Related Macular Degeneration Treatment revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Age Related Macular Degeneration Treatment Market Report

Report Metric	Details
Report Name	Age Related Macular Degeneration Treatment Market
Accounted market size in 2024	US$ 8128 million
Forecasted market size in 2030	US$ 9592.7 million
CAGR	2.8
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Lucentis Eylea Avastin Other
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Regeneron Pharmaceuticals, Bayer HealthCare, Novartis, Roche, Kanghong Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Age Related Macular Degeneration Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Age Related Macular Degeneration Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Age Related Macular Degeneration Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Age Related Macular Degeneration Treatment Market growing?

Ans: The Age Related Macular Degeneration Treatment Market witnessing a CAGR of 2.8 during the forecast period 2025-2030.

What is the Age Related Macular Degeneration Treatment Market size in 2030?

Ans: The Age Related Macular Degeneration Treatment Market size in 2030 will be US$ 9592.7 million.

Who are the main players in the Age Related Macular Degeneration Treatment Market report?

Ans: The main players in the Age Related Macular Degeneration Treatment Market are Regeneron Pharmaceuticals, Bayer HealthCare, Novartis, Roche, Kanghong Pharma

What are the Application segmentation covered in the Age Related Macular Degeneration Treatment Market report?

Ans: The Applications covered in the Age Related Macular Degeneration Treatment Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Age Related Macular Degeneration Treatment Market report?

Ans: The Types covered in the Age Related Macular Degeneration Treatment Market report are Lucentis, Eylea, Avastin, Other

Recommended Reports

Retinal Disorders

Macular Degeneration

Ophthalmic Treatments

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Age Related Macular Degeneration Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Lucentis

1.2.3 Eylea

1.2.4 Avastin

1.2.5 Other

1.3 Market by Application

1.3.1 Global Age Related Macular Degeneration Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Age Related Macular Degeneration Treatment Market Perspective (2019-2030)

2.2 Global Age Related Macular Degeneration Treatment Growth Trends by Region

2.2.1 Age Related Macular Degeneration Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Age Related Macular Degeneration Treatment Historic Market Size by Region (2019-2024)

2.2.3 Age Related Macular Degeneration Treatment Forecasted Market Size by Region (2025-2030)

2.3 Age Related Macular Degeneration Treatment Market Dynamics

2.3.1 Age Related Macular Degeneration Treatment Industry Trends

2.3.2 Age Related Macular Degeneration Treatment Market Drivers

2.3.3 Age Related Macular Degeneration Treatment Market Challenges

2.3.4 Age Related Macular Degeneration Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Age Related Macular Degeneration Treatment by Players

3.1.1 Global Age Related Macular Degeneration Treatment Revenue by Players (2019-2024)

3.1.2 Global Age Related Macular Degeneration Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Age Related Macular Degeneration Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Age Related Macular Degeneration Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Age Related Macular Degeneration Treatment Market Concentration Ratio

3.4.1 Global Age Related Macular Degeneration Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Age Related Macular Degeneration Treatment Revenue in 2023

3.5 Global Key Players of Age Related Macular Degeneration Treatment Head office and Area Served

3.6 Global Key Players of Age Related Macular Degeneration Treatment, Product and Application

3.7 Global Key Players of Age Related Macular Degeneration Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Age Related Macular Degeneration Treatment Breakdown Data by Type

4.1 Global Age Related Macular Degeneration Treatment Historic Market Size by Type (2019-2024)

4.2 Global Age Related Macular Degeneration Treatment Forecasted Market Size by Type (2025-2030)

5 Age Related Macular Degeneration Treatment Breakdown Data by Application

5.1 Global Age Related Macular Degeneration Treatment Historic Market Size by Application (2019-2024)

5.2 Global Age Related Macular Degeneration Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Age Related Macular Degeneration Treatment Market Size (2019-2030)

6.2 North America Age Related Macular Degeneration Treatment Market Size by Type

6.2.1 North America Age Related Macular Degeneration Treatment Market Size by Type (2019-2024)

6.2.2 North America Age Related Macular Degeneration Treatment Market Size by Type (2025-2030)

6.2.3 North America Age Related Macular Degeneration Treatment Market Share by Type (2019-2030)

6.3 North America Age Related Macular Degeneration Treatment Market Size by Application

6.3.1 North America Age Related Macular Degeneration Treatment Market Size by Application (2019-2024)

6.3.2 North America Age Related Macular Degeneration Treatment Market Size by Application (2025-2030)

6.3.3 North America Age Related Macular Degeneration Treatment Market Share by Application (2019-2030)

6.4 North America Age Related Macular Degeneration Treatment Market Size by Country

6.4.1 North America Age Related Macular Degeneration Treatment Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Age Related Macular Degeneration Treatment Market Size by Country (2019-2024)

6.4.3 North America Age Related Macular Degeneration Treatment Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Age Related Macular Degeneration Treatment Market Size (2019-2030)

7.2 Europe Age Related Macular Degeneration Treatment Market Size by Type

7.2.1 Europe Age Related Macular Degeneration Treatment Market Size by Type (2019-2024)

7.2.2 Europe Age Related Macular Degeneration Treatment Market Size by Type (2025-2030)

7.2.3 Europe Age Related Macular Degeneration Treatment Market Share by Type (2019-2030)

7.3 Europe Age Related Macular Degeneration Treatment Market Size by Application

7.3.1 Europe Age Related Macular Degeneration Treatment Market Size by Application (2019-2024)

7.3.2 Europe Age Related Macular Degeneration Treatment Market Size by Application (2025-2030)

7.3.3 Europe Age Related Macular Degeneration Treatment Market Share by Application (2019-2030)

7.4 Europe Age Related Macular Degeneration Treatment Market Size by Country

7.4.1 Europe Age Related Macular Degeneration Treatment Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Age Related Macular Degeneration Treatment Market Size by Country (2019-2024)

7.4.3 Europe Age Related Macular Degeneration Treatment Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Age Related Macular Degeneration Treatment Market Size (2019-2030)

8.2 China Age Related Macular Degeneration Treatment Market Size by Type

8.2.1 China Age Related Macular Degeneration Treatment Market Size by Type (2019-2024)

8.2.2 China Age Related Macular Degeneration Treatment Market Size by Type (2025-2030)

8.2.3 China Age Related Macular Degeneration Treatment Market Share by Type (2019-2030)

8.3 China Age Related Macular Degeneration Treatment Market Size by Application

8.3.1 China Age Related Macular Degeneration Treatment Market Size by Application (2019-2024)

8.3.2 China Age Related Macular Degeneration Treatment Market Size by Application (2025-2030)

8.3.3 China Age Related Macular Degeneration Treatment Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Age Related Macular Degeneration Treatment Market Size (2019-2030)

9.2 Asia Age Related Macular Degeneration Treatment Market Size by Type

9.2.1 Asia Age Related Macular Degeneration Treatment Market Size by Type (2019-2024)

9.2.2 Asia Age Related Macular Degeneration Treatment Market Size by Type (2025-2030)

9.2.3 Asia Age Related Macular Degeneration Treatment Market Share by Type (2019-2030)

9.3 Asia Age Related Macular Degeneration Treatment Market Size by Application

9.3.1 Asia Age Related Macular Degeneration Treatment Market Size by Application (2019-2024)

9.3.2 Asia Age Related Macular Degeneration Treatment Market Size by Application (2025-2030)

9.3.3 Asia Age Related Macular Degeneration Treatment Market Share by Application (2019-2030)

9.4 Asia Age Related Macular Degeneration Treatment Market Size by Region

9.4.1 Asia Age Related Macular Degeneration Treatment Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Age Related Macular Degeneration Treatment Market Size by Region (2019-2024)

9.4.3 Asia Age Related Macular Degeneration Treatment Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Age Related Macular Degeneration Treatment Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Age Related Macular Degeneration Treatment Market Size by Type

10.2.1 Middle East, Africa, and Latin America Age Related Macular Degeneration Treatment Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Age Related Macular Degeneration Treatment Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Age Related Macular Degeneration Treatment Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Age Related Macular Degeneration Treatment Market Size by Application

10.3.1 Middle East, Africa, and Latin America Age Related Macular Degeneration Treatment Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Age Related Macular Degeneration Treatment Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Age Related Macular Degeneration Treatment Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Age Related Macular Degeneration Treatment Market Size by Country

10.4.1 Middle East, Africa, and Latin America Age Related Macular Degeneration Treatment Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Age Related Macular Degeneration Treatment Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Age Related Macular Degeneration Treatment Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Regeneron Pharmaceuticals

11.1.1 Regeneron Pharmaceuticals Company Details

11.1.2 Regeneron Pharmaceuticals Business Overview

11.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Introduction

11.1.4 Regeneron Pharmaceuticals Revenue in Age Related Macular Degeneration Treatment Business (2019-2024)

11.1.5 Regeneron Pharmaceuticals Recent Developments

11.2 Bayer HealthCare

11.2.1 Bayer HealthCare Company Details

11.2.2 Bayer HealthCare Business Overview

11.2.3 Bayer HealthCare Age Related Macular Degeneration Treatment Introduction

11.2.4 Bayer HealthCare Revenue in Age Related Macular Degeneration Treatment Business (2019-2024)

11.2.5 Bayer HealthCare Recent Developments

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Age Related Macular Degeneration Treatment Introduction

11.3.4 Novartis Revenue in Age Related Macular Degeneration Treatment Business (2019-2024)

11.3.5 Novartis Recent Developments

11.4 Roche

11.4.1 Roche Company Details

11.4.2 Roche Business Overview

11.4.3 Roche Age Related Macular Degeneration Treatment Introduction

11.4.4 Roche Revenue in Age Related Macular Degeneration Treatment Business (2019-2024)

11.4.5 Roche Recent Developments

11.5 Kanghong Pharma

11.5.1 Kanghong Pharma Company Details

11.5.2 Kanghong Pharma Business Overview

11.5.3 Kanghong Pharma Age Related Macular Degeneration Treatment Introduction

11.5.4 Kanghong Pharma Revenue in Age Related Macular Degeneration Treatment Business (2019-2024)

11.5.5 Kanghong Pharma Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Regeneron Pharmaceuticals

Bayer HealthCare

Novartis

Roche

Kanghong Pharma

List of Tables

Table 1. Global Age Related Macular Degeneration Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Lucentis

Table 3. Key Players of Eylea

Table 4. Key Players of Avastin

Table 5. Key Players of Other

Table 6. Global Age Related Macular Degeneration Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Age Related Macular Degeneration Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Age Related Macular Degeneration Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Age Related Macular Degeneration Treatment Market Share by Region (2019-2024)

Table 10. Global Age Related Macular Degeneration Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Age Related Macular Degeneration Treatment Market Share by Region (2025-2030)

Table 12. Age Related Macular Degeneration Treatment Market Trends

Table 13. Age Related Macular Degeneration Treatment Market Drivers

Table 14. Age Related Macular Degeneration Treatment Market Challenges

Table 15. Age Related Macular Degeneration Treatment Market Restraints

Table 16. Global Age Related Macular Degeneration Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Age Related Macular Degeneration Treatment Revenue Share by Players (2019-2024)

Table 18. Global Top Age Related Macular Degeneration Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age Related Macular Degeneration Treatment as of 2023)

Table 19. Global Age Related Macular Degeneration Treatment Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Age Related Macular Degeneration Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Age Related Macular Degeneration Treatment, Headquarters and Area Served

Table 22. Global Key Players of Age Related Macular Degeneration Treatment, Product and Application

Table 23. Global Key Players of Age Related Macular Degeneration Treatment, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Age Related Macular Degeneration Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Age Related Macular Degeneration Treatment Revenue Market Share by Type (2019-2024)

Table 27. Global Age Related Macular Degeneration Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Age Related Macular Degeneration Treatment Revenue Market Share by Type (2025-2030)

Table 29. Global Age Related Macular Degeneration Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Age Related Macular Degeneration Treatment Revenue Share by Application (2019-2024)

Table 31. Global Age Related Macular Degeneration Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Age Related Macular Degeneration Treatment Revenue Share by Application (2025-2030)

Table 33. North America Age Related Macular Degeneration Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Age Related Macular Degeneration Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Age Related Macular Degeneration Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Age Related Macular Degeneration Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Age Related Macular Degeneration Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Age Related Macular Degeneration Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Age Related Macular Degeneration Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Age Related Macular Degeneration Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Age Related Macular Degeneration Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Age Related Macular Degeneration Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Age Related Macular Degeneration Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Age Related Macular Degeneration Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Age Related Macular Degeneration Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Age Related Macular Degeneration Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Age Related Macular Degeneration Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Age Related Macular Degeneration Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Age Related Macular Degeneration Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Age Related Macular Degeneration Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Age Related Macular Degeneration Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Age Related Macular Degeneration Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Age Related Macular Degeneration Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Age Related Macular Degeneration Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Age Related Macular Degeneration Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Age Related Macular Degeneration Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Age Related Macular Degeneration Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Age Related Macular Degeneration Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Age Related Macular Degeneration Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Age Related Macular Degeneration Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Age Related Macular Degeneration Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Age Related Macular Degeneration Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Age Related Macular Degeneration Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Age Related Macular Degeneration Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 65. Regeneron Pharmaceuticals Company Details

Table 66. Regeneron Pharmaceuticals Business Overview

Table 67. Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Product

Table 68. Regeneron Pharmaceuticals Revenue in Age Related Macular Degeneration Treatment Business (2019-2024) & (US$ Million)

Table 69. Regeneron Pharmaceuticals Recent Developments

Table 70. Bayer HealthCare Company Details

Table 71. Bayer HealthCare Business Overview

Table 72. Bayer HealthCare Age Related Macular Degeneration Treatment Product

Table 73. Bayer HealthCare Revenue in Age Related Macular Degeneration Treatment Business (2019-2024) & (US$ Million)

Table 74. Bayer HealthCare Recent Developments

Table 75. Novartis Company Details

Table 76. Novartis Business Overview

Table 77. Novartis Age Related Macular Degeneration Treatment Product

Table 78. Novartis Revenue in Age Related Macular Degeneration Treatment Business (2019-2024) & (US$ Million)

Table 79. Novartis Recent Developments

Table 80. Roche Company Details

Table 81. Roche Business Overview

Table 82. Roche Age Related Macular Degeneration Treatment Product

Table 83. Roche Revenue in Age Related Macular Degeneration Treatment Business (2019-2024) & (US$ Million)

Table 84. Roche Recent Developments

Table 85. Kanghong Pharma Company Details

Table 86. Kanghong Pharma Business Overview

Table 87. Kanghong Pharma Age Related Macular Degeneration Treatment Product

Table 88. Kanghong Pharma Revenue in Age Related Macular Degeneration Treatment Business (2019-2024) & (US$ Million)

Table 89. Kanghong Pharma Recent Developments

Table 90. Research Programs/Design for This Report

Table 91. Key Data Information from Secondary Sources

Table 92. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Age Related Macular Degeneration Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Age Related Macular Degeneration Treatment Market Share by Type: 2023 VS 2030

Figure 3. Lucentis Features

Figure 4. Eylea Features

Figure 5. Avastin Features

Figure 6. Other Features

Figure 7. Global Age Related Macular Degeneration Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Age Related Macular Degeneration Treatment Market Share by Application: 2023 VS 2030

Figure 9. Hospital Case Studies

Figure 10. Clinic Case Studies

Figure 11. Other Case Studies

Figure 12. Age Related Macular Degeneration Treatment Report Years Considered

Figure 13. Global Age Related Macular Degeneration Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Age Related Macular Degeneration Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Age Related Macular Degeneration Treatment Market Share by Region: 2023 VS 2030

Figure 16. Global Age Related Macular Degeneration Treatment Market Share by Players in 2023

Figure 17. Global Top Age Related Macular Degeneration Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age Related Macular Degeneration Treatment as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Age Related Macular Degeneration Treatment Revenue in 2023

Figure 19. North America Age Related Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Age Related Macular Degeneration Treatment Market Share by Type (2019-2030)

Figure 21. North America Age Related Macular Degeneration Treatment Market Share by Application (2019-2030)

Figure 22. North America Age Related Macular Degeneration Treatment Market Share by Country (2019-2030)

Figure 23. United States Age Related Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Age Related Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Age Related Macular Degeneration Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Age Related Macular Degeneration Treatment Market Share by Type (2019-2030)

Figure 27. Europe Age Related Macular Degeneration Treatment Market Share by Application (2019-2030)

Figure 28. Europe Age Related Macular Degeneration Treatment Market Share by Country (2019-2030)

Figure 29. Germany Age Related Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Age Related Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Age Related Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Age Related Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Age Related Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Age Related Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Age Related Macular Degeneration Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Age Related Macular Degeneration Treatment Market Share by Type (2019-2030)

Figure 37. China Age Related Macular Degeneration Treatment Market Share by Application (2019-2030)

Figure 38. Asia Age Related Macular Degeneration Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Age Related Macular Degeneration Treatment Market Share by Type (2019-2030)

Figure 40. Asia Age Related Macular Degeneration Treatment Market Share by Application (2019-2030)

Figure 41. Asia Age Related Macular Degeneration Treatment Market Share by Region (2019-2030)

Figure 42. Japan Age Related Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Age Related Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Age Related Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Age Related Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Age Related Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Age Related Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Age Related Macular Degeneration Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Age Related Macular Degeneration Treatment Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Age Related Macular Degeneration Treatment Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Age Related Macular Degeneration Treatment Market Share by Country (2019-2030)

Figure 52. Brazil Age Related Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Age Related Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Age Related Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Age Related Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Age Related Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Age Related Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Regeneron Pharmaceuticals Revenue Growth Rate in Age Related Macular Degeneration Treatment Business (2019-2024)

Figure 59. Bayer HealthCare Revenue Growth Rate in Age Related Macular Degeneration Treatment Business (2019-2024)

Figure 60. Novartis Revenue Growth Rate in Age Related Macular Degeneration Treatment Business (2019-2024)

Figure 61. Roche Revenue Growth Rate in Age Related Macular Degeneration Treatment Business (2019-2024)

Figure 62. Kanghong Pharma Revenue Growth Rate in Age Related Macular Degeneration Treatment Business (2019-2024)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Ophthalmology for Age related Macular Degeneration Diseases Market Research Report 2024

Global Macular Degeneration Treatment Market Research Report 2024

Global Macular Degeneration AMD and Other Retinal Diseases Market Research Report 2024

Global Macular Edema and Macular Degeneration Market Research Report 2025

Global Retinal Disorders Treatment Market Research Report 2024

Global Wet Macular Degeneration Market Research Report 2024

Global Ophthalmology Disorders Drug Market Insights Forecast to 2030

Geographic Atrophy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Open Angle Glaucoma Therapeutics Market Insights Forecast to 2030

Retinal Degenerative Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Neurodegenerative Disease Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions